Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through γ-aminobutyric acid and γ-aminobutyric acid type B receptors

Journal of Neuroscience Research

Volumn 79, Issue 3, 2005, Pages 412-420

  Kombian, Samuel B ^a   Ananthalakshmi, Kethireddy V V ^a   Parvathy, Subramanian S ^a   Matowe, Wandikayi C ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Adenylyl cyclase; CCKB receptors; PKA; Synaptic transmission

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE ACTIVATOR; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DOPAMINE RECEPTOR BLOCKING AGENT; FORSKOLIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROGLUMIDE; SULPIRIDE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; INHIBITORY POSTSYNAPTIC POTENTIAL; MEMBRANE POTENTIAL; NERVE EXCITABILITY; NONHUMAN; NUCLEUS ACCUMBENS; PATCH CLAMP; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

ADENYLATE CYCLASE; ANIMALS; CHOLECYSTOKININ; EXTRACELLULAR FLUID; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MEMBRANE POTENTIALS; NEURAL INHIBITION; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, GABA-B; SYNAPSES; SYNAPTIC TRANSMISSION; UP-REGULATION;

EID: 14044278790     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20349     Document Type: Article

References (48)

1. Beinfeld MC, Garver DL. 1991. Concentration of cholecystokinin in cerebrospinal fluid is decreased in psychosis: relationship to symptoms and drug response. Prog Neuropsychopharmacol Biol Psychiatry 15:601-609.
2. Berresford IJM, Hall MD, Clark CR, Hill RG, Hughes J, Sirinathsinghji DJ. 1987. Striatal lesions and transplants demonstrate that CCK receptors are localized on intrinsic striatal neurons: a quantitative autoradiographic study. Neuropeptides 10:109-136.
3. Bourin M, Malinge M, Vasar E, Bradwejn J. 1996. Two faces of cholecystokinin: anxiety and schizophrenia. Fund Clin Pharmacol 10:116-126.
4. Branchereau P, Champagnat J, Denavit-Saubie M. 1993. Cholecystokinin- gated currents in neurons of the rat solitary complex in vitro. J Neurophysiol 70:2584-2595.
5. Brog JS, Salyapongse A, Deutch AY, Zahm DS. 1993. The patterns of afferent innervation of the core and shell in the "accumbens" part of the rat ventral striatum: immunohistochemical detection of retrogradely transported fluro-gold. J Comp Neurol 338:255-278.
6. Capogna M, Gahwiler BH, Thompson SM. 1995. Presynaptic enhancement of inhibitory synaptic transmission by protein kinase A and C in the rat hippocampus. J Neurosci 15:1249-1260.
7. Crespi F. 1998. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonists in the spontaneous preference for drugs of abuse (alcohol or cocaine) in naive rats. Methods Find Exp Clin Pharmacol 20:679-697.
8. Detjen K, Yule D, Tseng M-J, Williams JA, Logsdon CD. 1997. CCK-B receptors produce similar signals but have opposite growth effects in CHO and Swiss 3T3 cells. Am J Physiol 273:C1449-C1457.
9. Feifel D, Swerdlow NR. 1997. The modulation of sensorimotor gating deficits by mesolimbic cholecystokinin. Neurosci Lett 229:5-8.
10. Feifel D, Reza T, Robeck S. 1999. Antipsychotic potential of CCK-based treatments: an assessment using the prepulse inhibition model of psychosis. Neuropsychopharmacology 20:141-149.
11. Ferraro L, O'Connor WT, Li XM, Rimondini R, Beani L, Ungerstedt U, Fuxe K, Tanganelli S. 1996. Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanisms. Neuroscience 73:941-950.
12. 1 receptors activation. J Physiol 492:143-154.
13. Higgins GA, Sills TL, Tomkins DM, Sellers EM, Vaccarino FJ. 1994. Evidence for the contribution of CCKB receptor mechanisms to individual differences in amphetamine-induced locomotion. Pharmacol Biochem Behav 48:1019-1024.
14. Hokfelt T, Lundberg JM, Schultzberg M, Johansson O, Skirboll L, Anggard A, Fredholm B, Hamberger B, Pernow B, Rehfeld J, Goldstein M. 1980. Cellular localization of peptides in neural structures. Proc R Soc Lond B Biol Sci 210:63-77.
15. Joost HG, Habberfield AD, Simpson IA, Laurenza A, Seamon KB. 1988. Activation of adenylate cyclase and inhibition of glucose transport in rat adiposcytes by forskolin analogues: structural determinants of distinct sites of action. Mol Pharmacol 33:449-453.
16. Kano M, Konnerth A. 1992. Potentiation of GABA-mediated currents by cAMP-dependent protein kinase. Neuroreport 3:563-566.
17. A receptor currents. J Neurophysiol 76:2626-2634.
18. Kombian SB, Ananthalakshmi KVV, Parvathy SS, Matowe WC. 2003a. Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms. J Neurophysiol 89:728-738.
19. Kombian SB, Ananthalakshmi KV, Parvathy SS, Matowe WC. 2003b. Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro. Eur J Neurosci 18:303-311.
20. Kombian SB, Ananthalakshmi KVV, Parvathy SS, Matowe WC. 2004. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro. J Physiol 555:71-84.
21. Kondo S, Marty A. 1997. Protein kinase A-mediated enhancement of miniature IPSC frequency by adrenaline in rat cerebellar stellar cells. J Physiol 498:165-176.
22. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
23. Kuhar MJ, Ritz MC, Boja JW. 1991. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
24. Lanca AJ, De Cabo C, Arifuzzaman AI, Vaccarino FJ. 1998. Cholecysto-kinergic innervation of nucleus accumbens subregions. Peptides 19:859-868.
25. Lane RF, Blaha CD, Phillips AG. 1986. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens. Brain Res 397:200-204.
26. Lanza M, Makovec F. 2000. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons. Naunyn Schmiedebergs Arch Pharmacol 361:33-38.
27. A receptor β subunits determine regulation by cAMP-dependent protein kinase. Nat Neurosci 1:23-28.
28. Mercer LD, Le VQ, Nunan J, Jones NM, Beart PM. 2000. Direct visualization of cholecystokinin subtype2 receptors in rat central nervous system using anti-peptide antibodies. Neurosci Lett 293:167-170.
29. + conductance in hippocampal interneurones. J Neurosci 17:4994-5003.
30. A receptors by cAMP-dependent protein phosphorylation. Science 257:661-665.
31. Nicola SM, Malenka RC. 1997. Dopamine depresses excitatory and inhibitory synaptic transmission by distinct mechanisms in the nucleus accumbens. J Neurosci 17:5697-5710.
32. A receptors by cAMP-dependent protein kinase in mouse cerebellar and olfactory bulb neurones. J Physiol 521:421-435.
33. 2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 634:105-112.
34. Pennartz CM, Groenewegen HJ, Lopes da Silva FH. 1994. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioral, electrophysiological and anatomical data. Prog Neurobiol 42:719-761.
35. Pommier B, Da Nascimento S, Dumont S, Bellier B, Million E, Garbay C, Roques BP, Noble F. 1999. The cholecystokininB receptor is coupled to two effector pathways through pertussis toxin-sensitive and -insensitive G proteins. J Neurochem 73:281-288.
36. Rotzinger S, Vaccarino FJ. 2003. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviors in animal models. J Psychiatry Neurosci 28:171-181.
37. Ruggeri M, Ungerstedt U, Agnati L, Mutt V, Harfstrand A, Fuxe K. 1987. Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using iontracerebral dialysis in the anaesthetized rat. Neurochem Int 10:509-520.
38. Seroogy KB, Fallon JH. 1989. Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain. J Comp Neurol 279:415-435.
39. Swerdlow NR, Koob GF. 1984. The neural substrates of apomorphine- stimulated locomotor activity following denervation of the nucleus accumbens. Life Sci 35:2537-2544.
40. Uchimura N, North RA. 1991. Baclofen and adenosine inhibit synaptic potentials mediated by gamma-aminobutyric acid and glutamate release in rat nucleus accumbens. J Pharmacol Exp Ther 258:663-668.
41. Vaccarino FJ. 1994. Nucleus accumbens dopamine-CCK interactions in psychostimulant reward and related behaviors. Neurosci Biobehav Rev 18:207-214.
42. Voigt M, Wang RY, Westfall TC. 1986. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro. J Pharmacol Exp Ther 237:147-153.
43. Wank SA. 1998. G protein-coupled receptors in gastrointestinal physiology 1. CCK receptors: an examplary family. Am J Physiol 37:G607-G613.
44. Wei JY, Roy DS, Leconte L, Barnstable CJ. 1998. Molecular and pharmacological analysis of cyclic nucleotide-gated channel function in the central nervous system. Prog Neurobiol 56:37-64.
45. Wu T, Wang H-L. 1996. The excitatory effect of cholecystokinin on rat neostriatal neurons:ionic and molecular mechanisms. Eur J Pharmacol 307:125-132.
46. Yu MJ, Thrasher KJ, McCowan JR, Mason NR, Mendelsohn LG. 1991. Quinazolinone cholecystokinin-B receptor ligands. J Med Chem 34:1505-1508.
47. Zaborszky L, Alheid GF, Beinfeld MC, Eiden LE, Heimer L, Palkovits M. 1985. Cholecystokinin innervation of the ventral striatum: a morphological and radioimmunological study. Neuroscience 14:427-453.
48. Zahm DS, Borg JS. 1992. On the significance of the subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience 50:751-767.